Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China

被引:32
|
作者
Hsing, Ann W.
Gao, Yu-Tang
McGlynn, Katherine A.
Niwa, Shelley
Zhang, Mingdong
Han, Tian-Quan
Wang, Bing-Sheng
Chen, Jinbo
Sakoda, Lori C.
Shen, Ming-Chang
Zhang, Bai-He
Deng, Jie
Rashid, Asif
机构
[1] Natl Canc Inst, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
[2] Shanghai Canc Inst, Shanghai, Peoples R China
[3] Hlth Studies Sector, Rockville, MD USA
[4] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Hong Kong, Peoples R China
[5] Raijin Hosp, Dept Surg, Shanghai, Peoples R China
[6] Shanghai Med Univ, Zhongshan Hosp, Dept Surg, Shanghai 200032, Peoples R China
[7] Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA USA
[8] Shanghai Tumor Hosp, Dept Pathol, Shanghai, Peoples R China
[9] Second Mil Hosp, Dept Surg, Shanghai, Peoples R China
[10] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
biliary tract cancer; family history; viral hepatitis; liver cirrhosis; family history of liver cancer; China;
D O I
10.1002/ijc.22375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biliary tract cancers are relatively rare but fatal tumors. Apart from a close link with gallstones and cholangitis, risk factors for biliary tract cancer are obscure. Chronic liver conditions, including liver cirrhosis, have been linked to a higher risk of biliary tract cancer. In a population-based case-control study conducted in Shanghai, China, we investigated the relationships of a history of chronic hepatitis and liver cirrhosis as well as a family history of liver cancer with biliary tract cancer risk. The study included 627 patients with biliary tract cancers (368 gallbladder, 191 bile duct and 68 ampulla of Vater), 1,037 patients with biliary stones (774 gallbladder stones and 263 bile duct stones) and 959 healthy subjects randomly selected from the population. Bile duct cancer was associated with self-reports of chronic liver conditions, including a history of chronic hepatitis (OR = 2.0, 95% CI 0.9-4.4), liver cirrhosis (OR = 4.7, 95% CI 1.9-11.7) and a family history of primary liver cancer (OR = 2.0, 95% CI 1.0-3.9). The excess risk persisted after adjustment for gallstones and were more pronounced among subjects without gallstones (OR = 5.0, 95% CI 1.3-20.0 and OR = 4.9, 95% 2.0-12.2, respectively). History of liver conditions was also associated with an excess of biliary stones (OR = 1.9, 95% CI 1.2-3.0). No association was found for cancers of the gallbladder and ampulla of Vater. A history of chronic hepatitis and cirrhosis may be risk factors for extraheptic bile duct cancer. Given that chronic infection with hepatitis B virus (HBV) is the most common cause of liver disease in China, serologic markers of HBV need to be measured in future studies to examine the link between HBV and bile duct cancer. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1981 / 1985
页数:5
相关论文
共 50 条
  • [31] GREEN-TEA CONSUMPTION AND RISK OF STOMACH-CANCER - A POPULATION-BASED CASE-CONTROL STUDY IN SHANGHAI, CHINA
    YU, GP
    HSIEH, CC
    WANG, LY
    YU, SZ
    LI, XL
    JIN, TH
    CANCER CAUSES & CONTROL, 1995, 6 (06) : 532 - 538
  • [32] Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai
    Xu, Hui-Lin
    Fang, Hong
    Xu, Wang-Hong
    Qin, Guo-You
    Yan, Yu-Jie
    Yao, Bao-Dong
    Zhao, Nai-Qing
    Liu, Yi-Nan
    Zhang, Fen
    Li, Wei-Xi
    Wang, Na
    Zhou, Jie
    Zhang, Jin-Ling
    Zhao, Li-Yun
    Li, Lun-Qiang
    Zhao, Yan-Ping
    BMC CANCER, 2015, 15
  • [33] Factors affecting the place of death in patients with liver cancer in China, 2013-2020: A population-based study
    Ding, Xiaosheng
    Shi, Weiwei
    Qi, Jinlei
    An, Juan
    Xu, Weiran
    Shi, Hui
    Zheng, Xixi
    Li, Xiaoyan
    CANCER PATHOGENESIS AND THERAPY, 2025, 3 (02): : 163 - 172
  • [34] Cyp17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia:: A population-based study in China
    Madigan, MP
    Gao, YT
    Deng, J
    Pfeiffer, RM
    Chang, BL
    Zheng, SQ
    Meyers, DA
    Stanczyk, FZ
    Xu, JF
    Hsing, AW
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (02) : 271 - 275
  • [35] Epidemiology of urticaria in China: a population-based study
    Li, Jiaqing
    Mao, Dandan
    Liu, Shuoshuo
    Liu, Ping
    Tian, Jing
    Xue, Chenhong
    Liu, Xiaojing
    Qi, Ruiqun
    Bai, Bingxue
    Nie, Jianjun
    Ye, Siqi
    Wang, Yu
    Li, Yuye
    Sun, Qing
    Tao, Juan
    Guo, Shuping
    Fang, Hong
    Wang, Jianqin
    Mu, Qiri
    Liu, Quanzhong
    Ding, Yan
    Zhang, Jianzhong
    CHINESE MEDICAL JOURNAL, 2022, 135 (11) : 1369 - 1375
  • [36] Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry
    Ashkbari, Ali
    Amlashi, Fazel Isapanah
    Besharat, Sima
    Mofidi, Mostafa
    Amiriani, Taghi
    Fazel, Abdolreza
    Alimadadi, Mehdi
    Salamat, Faezeh
    Sedaghat, Seyed Mehdi
    Livani, Somayeh
    Bagheri, Ali
    Semnani, Shahriyar
    Norouzi, Alireza
    Roshandel, Gholamreza
    ARCHIVES OF IRANIAN MEDICINE, 2023, 26 (09) : 504 - 509
  • [37] Survey of hepatitis B virus infection for liver cancer screening in China: A population-based, cross-sectional study
    Xu Yongjie
    Xia Changfa
    Li He
    Cao Maomao
    Yang Fan
    Li Qianru
    Cao Mengdi
    Chen Wanqing
    中华医学杂志英文版, 2024, 137 (12)
  • [38] Variants in circadian genes and prostate cancer risk: a population-based study in China
    L W Chu
    Y Zhu
    K Yu
    T Zheng
    H Yu
    Y Zhang
    I Sesterhenn
    A P Chokkalingam
    K N Danforth
    M-C Shen
    F Z Stanczyk
    Y-T Gao
    A W Hsing
    Prostate Cancer and Prostatic Diseases, 2008, 11 : 342 - 348
  • [39] The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study
    Zhu, Qixun
    Liu, Junli
    Hu, Junrong
    Zhang, Yanting
    THYROID, 2025, : 307 - 320
  • [40] Survey of hepatitis B virus infection for liver cancer screening in China: A population-based, cross-sectional study
    Xu, Yongjie
    Xia, Changfa
    Li, He
    Cao, Maomao
    Yang, Fan
    Li, Qianru
    Cao, Mengdi
    Chen, Wanqing
    CHINESE MEDICAL JOURNAL, 2024, 137 (12) : 1414 - 1420